Transaction in Own Shares

Summary by AI BETAClose X

Fevertree Drinks plc has announced the purchase of 206,083 ordinary shares between July 13th and July 17th, 2026, with an aggregated volume-weighted average price of approximately 787.75 pence per share, ranging from 761.00 pence to 820.00 pence. These shares were acquired through its broker, Investec Bank plc, under shareholder authority and are intended for cancellation.

Disclaimer*

Fevertree Drinks PLC
21 July 2026
 

21st July 2026                         

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 13th July to 17th July 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

13 July 2026

XLON

773.9725

22,532

767.0000

783.0000

14 July 2026

XLON

775.1759

37,904

761.0000

794.0000

14 July 2026

AIMX

765.0000

20,000

765.0000

765.0000

15 July 2026

XLON

795.5166

57,106

776.0000

800.0000

16 July 2026

XLON

806.9910

46,890

792.0000

812.5000

16 July 2026

AIMX

810.0000

9,465

810.0000

810.0000

17 July 2026

XLON

815.2215

34,232

808.0000

820.0000

17 July 2026

AIMX

813.0000

21,050

813.0000

813.0000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.


http://www.rns-pdf.londonstockexchange.com/rns/9992M_1-2026-7-20.pdf



This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings